Open Access

Activation of GPER by E2 promotes proliferation, invasion and migration of breast cancer cells by regulating the miR‑124/CD151 pathway

  • Authors:
    • Huaicheng Yang
    • Congyu Wang
    • Heqiang Liao
    • Qi Wang
  • View Affiliations

  • Published online on: March 31, 2021     https://doi.org/10.3892/ol.2021.12693
  • Article Number: 432
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Breast cancer is one of the most common malignancies worldwide and is responsible for a high mortality rate. However, the underlying pathological mechanism of breast cancer remains unclear. MicroRNAs (miRNAs/miRs) play critical roles in the progression of breast cancer. Recent studies have reported that miR‑124/CD151 participates in the development of breast cancer. However, the exact molecular mechanism of miR‑124/CD151 action in 17β‑estradiol (E2)‑treated breast cancer cells remains unknown. Thus, the present study aimed to investigate miR‑124 and CD151 expression levels in MCF‑7 cells treated with E2 via reverse transcription‑quantitative PCR and western blot analyses. Bioinformatic analysis was performed to predict and identify whether CD151 is a potential target of miR‑124. The Cell Counting Kit‑8 and colony formation assays were performed to detect proliferation of MCF‑7 cells. In addition, the invasive and migratory abilities of MCF‑7 cells were assessed via the Transwell and wound healing assays, respectively. The results demonstrated that E2 downregulated miR‑124 expression, while upregulating G protein ‑coupled estrogen receptor (GPER) expression in MCF‑7 cells. Following treatment with the GPER antagonist, G15, miR‑124 expression was significantly enhanced and E2‑induced proliferation, invasion and migration of MCF‑7 cells were notably inhibited. In addition, CD151 was confirmed as a direct target of miR‑124. CD151 silencing remarkably suppressed the proliferation, invasion and migration of E2‑induced MCF‑7 cells. Taken together, these results suggest that upregulation of GPER expression induced by E2 promotes proliferation, invasion and migration of breast cancer cells by regulating the miR‑124/CD151 pathway. Thus, the results of the present study provide a potential novel method for the treatment and prognosis of breast cancer.
View Figures
View References

Related Articles

Journal Cover

June-2021
Volume 21 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang H, Wang C, Liao H and Wang Q: Activation of GPER by E2 promotes proliferation, invasion and migration of breast cancer cells by regulating the miR‑124/CD151 pathway. Oncol Lett 21: 432, 2021.
APA
Yang, H., Wang, C., Liao, H., & Wang, Q. (2021). Activation of GPER by E2 promotes proliferation, invasion and migration of breast cancer cells by regulating the miR‑124/CD151 pathway. Oncology Letters, 21, 432. https://doi.org/10.3892/ol.2021.12693
MLA
Yang, H., Wang, C., Liao, H., Wang, Q."Activation of GPER by E2 promotes proliferation, invasion and migration of breast cancer cells by regulating the miR‑124/CD151 pathway". Oncology Letters 21.6 (2021): 432.
Chicago
Yang, H., Wang, C., Liao, H., Wang, Q."Activation of GPER by E2 promotes proliferation, invasion and migration of breast cancer cells by regulating the miR‑124/CD151 pathway". Oncology Letters 21, no. 6 (2021): 432. https://doi.org/10.3892/ol.2021.12693